Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

UnitedHealth Group Inc. diskutieren

UnitedHealth Group Inc.

WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Aktie / Anbieter & Dienstleistungen / Large Cap /

291,20 €
1,59 %

Einschätzung Buy
Rendite (%) -44,37 %
Kursziel 617,29
Veränderung
Endet am 11.10.25

UnitedHealth Group Incorporated (NYSE: UNH) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $675.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group Incorporated (NYSE: UNH) was upgraded by analysts at KeyCorp to a "strong-buy" rating.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,05 %
Kursziel 596,90
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Bank of America Co. from $675.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,05 %
Kursziel 560,16
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Morgan Stanley from $615.00 to $610.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,36 %
Kursziel 546,33
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Royal Bank of Canada from $615.00 to $595.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -42,53 %
Kursziel 574,69
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $625.00 price target on the stock, down previously from $640.00.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -42,53 %
Kursziel 592,16
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Cantor Fitzgerald from $591.00 to $644.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -42,53 %
Kursziel 556,30
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Stephens from $632.00 to $605.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -42,53 %
Kursziel 597,87
Veränderung
Endet am 16.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at UBS Group AG from $680.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,22 %
Kursziel 560,95
Veränderung
Endet am 18.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at TD Cowen from $601.00 to $609.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,67 %
Kursziel 557,53
Veränderung
Endet am 22.10.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Barclays PLC from $604.00 to $603.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -51,02 %
Kursziel 620,29
Veränderung
Endet am 27.11.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Barclays PLC from $603.00 to $655.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -49,40 %
Kursziel 593,63
Veränderung
Endet am 03.12.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $595.00 to $625.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -45,70 %
Kursziel 605,63
Veränderung
Endet am 06.12.25

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Oppenheimer Holdings Inc. from $610.00 to $640.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -40,50 %
Kursziel 581,64
Veränderung
Endet am 02.01.26

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Piper Sandler from $605.00 to $600.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -40,63 %
Kursziel 587,43
Veränderung
Endet am 06.01.26

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at Truist Financial Co. from $625.00 to $610.00. They now have a "buy" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -43,10 %
Kursziel 580,07
Veränderung
Endet am 10.01.26

UnitedHealth Group Incorporated (NYSE: UNH) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $595.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group Incorporated (NYSE: UNH) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,46 %
Kursziel 680,47
Veränderung
Endet am 17.01.26

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $700.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -41,92 %
Kursziel 631,02
Veränderung
Endet am 17.01.26

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at KeyCorp. They now have a $650.00 price target on the stock.
Ratings data for UNH provided by MarketBeat